Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance Press Release Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…Certara2026 年 2 月 26 日
Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD) Guide Guided by Evidence: Implementing the ICH M15 Guideline for Model-Informed Drug Development (MIDD) Prepare for ICH M15 guideline: Learn how to assess model credibility, align terminology, and strengthen…Certara2026 年 2 月 13 日
EMA Policy 0070 Submission Readiness Checklist Guide EMA Policy 0070 Submission Readiness Checklist Use this EMA Policy 0070 Submission Checklist to prepare compliant clinical data packages, manage anonymization…Certara2026 年 2 月 12 日
Pediatric Drug Development: From “Wild West” to Model-Informed Confidence Blog Pediatric Drug Development: From “Wild West” to Model-Informed Confidence Model-informed drug development and precision dosing are transforming pediatric programs, from regulatory planning to Bayesian…Certara2026 年 2 月 11 日
Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants Publication Population Pharmacokinetics of Clesrovimab in Preterm and Full-Term Infants This study, published in Clinical Pharmacology & Therapeutics (CPT), shows how population pharmacokinetic modeling supports…Certara2026 年 2 月 2 日
Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach Press Coverage Opinion: To Accelerate Rare Disease Progress, Take a Sandbox Approach Explore how a collaborative “sandbox” approach—combining flexible regulation, data modeling, and stakeholder engagement—can transform rare…Certara2026 年 1 月 30 日
Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients Publication Combining Aggregate Data and Individual Patient Data in Model-Based Meta-Analysis: An Illustrative Case Study of Tofacitinib in Rheumatoid Arthritis Patients This article explores how model-based meta-analysis (MBMA) performs when combining aggregate data and individual patient…Certara2026 年 1 月 22 日
Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy On-Demand Webinar Model-Based Meta-Analysis (MBMA), Quantitative Systems Pharmacology (QSP), and Advanced Modeling in Early Reimbursement Strategy Watch this on-demand webinar to learn how model-based meta-analysis (MBMA), quantitative systems pharmacology (QSP), and…Certara2026 年 1 月 22 日
Adaptive clinical trials in oncology: Meeting the challenge of Project Optimus Blog 肿瘤精准剂量革命:Project Optimus下的适应性临床试验新范式 Leveraging adaptive clinical trial designs in oncology can accelerate drug development, while following the FDA…Certara2026 年 1 月 16 日